Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human stem cell and gene therapy

This publication has 40 references indexed in Scilit:

• Improvements in Mucopolysaccharidosis I Mice After Adult Retroviral Vector–mediated Gene Therapy with Immunomodulation
  Molecular Therapy, 2007
• Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells
  Blood, 2005
• Cardiac manifestations in the mouse model of mucopolysaccharidosis I
  Molecular Genetics and Metabolism, 2005
• Gene Therapy for a Mucopolysaccharidosis Type I Murine Model with Lentiviral-IDUA Vector
  Human Gene Therapy, 2005
• Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice
  Molecular Therapy, 2005
• Motor and cognitive function evaluation following experimental traumatic brain injury
  Published by Elsevier ,2004
• Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human α-l-iduronidase gene
  Molecular Therapy, 2004
• Enzyme Replacement Therapy in Feline Mucopolysaccharidosis I
  Molecular Genetics and Metabolism, 2001
• Assay of human stem cells by repopulation of NOD/SCID mice
  The International Journal of Cell Cloning, 1997
• A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding
  Analytical Biochemistry, 1976